Blog | Think Bold, Think Scientific, Think Veristat

1 min read

Veristat Raises >$350K For Rare Cancer Research

Team Veristat Participate in Cycle for Survival 2021 - Virtually

For the past seven years, Veristat has participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club...

1 min read

Beating Rare Cancers Requires Your Help - JOIN THE BATTLE TODAY!

As a scientifically oriented and impactful full-service clinical research organization (CRO) that is committed to partnering with pharmaceutical, biotechnology, and medical device firms to advance their therapies throughout the entire clinical...

3 min read

Flexibility is the Key to Data Acquisition for Rare Disease Trials

Understanding Why Creative Data Collection Solutions Are Necessary

2 min read

Competing Risk Analysis in Clinical Trials | A Practical Example

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy.